SCHEMBL98818

SCHEMBL98818

O=C(CCS)OCCOCCOCCOC(=O)CCS

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.41
ALDH1A1 P00352 3/20 0.39
TSHR P16473 3/20 0.39
TP53 P04637 2/20 0.39
HIF1A Q16665 2/20 0.39
HSD17B10 Q99714 2/20 0.39
ADRA2A P08913 1/20 0.39
ADRA1A P35348 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
MAPT P10636 1/20 0.38
BLM P54132 1/20 0.38
FNTA P49354 1/20 0.36
FNTB P49356 1/20 0.36
DNM1 Q05193 1/20 0.34
APP P05067 1/20 0.32
SERPINE1 P05121 1/20 0.32
ACE P12821 2/20 0.32
EPHX2 P34913 2/20 0.32
THRB P10828 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL98263 1.00 DGKA (0.41) DGKAALDH1A1TSHRTP53HIF1A
SCHEMBL98157 1.00 DGKA (0.41) DGKAALDH1A1TSHRTP53HIF1A
SCHEMBL15426704 0.95 DGKA (0.39) DGKAALDH1A1TSHRTP53HIF1A
SCHEMBL16330332 0.93 DGKA (0.38) DGKAALDH1A1TSHRTP53HIF1A
SCHEMBL98980 0.92 DGKA (0.46) DGKATSHRHSD17B10ADRA2AADRA1A
SCHEMBL23349392 0.91 DGKA (0.41) DGKAALDH1A1TSHRTP53HIF1A
SCHEMBL6036438 0.91 MEN1 (0.46) DGKAALDH1A1TSHRTP53HIF1A
SCHEMBL27776824 0.91 MEN1 (0.46) DGKAALDH1A1TSHRTP53HIF1A
SCHEMBL432620 0.91 MEN1 (0.46) DGKAALDH1A1TSHRTP53HIF1A
SCHEMBL22343450 0.89 DGKA (0.39) DGKAALDH1A1TSHRTP53HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12492293-B2 Multi-component systems for preparing foamed products ARKEMA FRANCE (FR) 2025-12-09 US disclosed
US-12240868-B2 Organic silicon compound and production method therefor SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-03-04 US disclosed
CN-111989333-B Organosilicon compound and method for producing same 信越化学工业株式会社 2023-09-15 CN disclosed
EP-3891210-B1 MULTI-COMPONENT SYSTEMS FOR PREPARING FOAMED PRODUCTS ARKEMA FRANCE (FR) 2023-08-23 EP disclosed
EP-3138862-B1 POLYMERIZABLE COMPOSITION FOR OPTICAL MATERIALS, OPTICAL MATERIAL PRODUCED FROM SAME, AND METHOD FOR PRODUCING SAME MITSUI CHEMICALS INC (JP) 2022-08-03 EP disclosed
EP-3109268-B1 METHOD FOR MANUFACTURING OPTICAL MATERIAL MITSUI CHEMICALS INC (JP) 2022-03-30 EP disclosed
US-20220033606-A1 MULTI-COMPONENT SYSTEMS FOR PREPARING FOAMED PRODUCTS ARKEMA FRANCE (FR) 2022-02-03 US disclosed
EP-3891210-A1 MULTI-COMPONENT SYSTEMS FOR PREPARING FOAMED PRODUCTS ARKEMA FRANCE (FR) 2021-10-13 EP disclosed
US-11130891-B2 Photocurable sealing material BOSTIK SA (FR) 2021-09-28 US disclosed
US-20210163512-A1 ORGANIC SILICON COMPOUND AND PRODUCTION METHOD THEREFOR SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-06-03 US disclosed
US-20150080509-A1 PHOTOCURABLE MATERIAL FOR SEALING, SEALING METHOD, SEALING MATERIAL, AND HOUSING USING SAID SEALING MATERIAL NITTA GELATIN KK (JP) 2015-03-19 US disclosed
US-8921446-B2 Photocurable material for sealing, sealing method, sealing material, and housing using said sealing material NITTA GELATIN INC. (JP) 2014-12-30 US disclosed
US-20140327869-A1 POLYMERIZABLE COMPOSITION, OPTICAL ARTICLE OBTAINED THEREFROM AND METHOD FOR THE PRODUCTION OF SAID OPTICAL ARTICLE MITSUI CHEMICALS, INC. 2014-11-06 US disclosed
EP-2780387-A1 POLYMERIZABLE COMPOSITION, OPTICAL ARTICLE OBTAINED THEREFROM AND METHOD FOR THE PRODUCTION OF SAID OPTICAL ARTICLE Mitsui Chemicals, Inc. (JP) 2014-09-24 EP disclosed
US-20130303651-A1 PHOTOCURABLE MATERIAL FOR SEALING, SEALING METHOD, SEALING MATERIAL, AND HOUSING USING SAID SEALING MATERIAL BOSTIK SA (FR) 2013-11-14 US disclosed
WO-2013073194-A1 POLYMERIZABLE COMPOSITION, OPTICAL ARTICLE OBTAINED THEREFROM AND METHOD FOR THE PRODUCTION OF SAID OPTICAL ARTICLE MITSUI CHEMICALS, INC. (JP) 2013-05-23 WO disclosed
EP-2471873-A1 ENERGY RAY-CURABLE ELASTOMER COMPOSITION Bridgestone Corporation (JP) 2012-07-04 EP disclosed
US-20120157564-A1 ENERGY RAY-CURABLE ELASTOMER COMPOSITION BRIDGESTONE CORPORATION (JP) 2012-06-21 US disclosed
EP-2426162-A1 ENERGY-RAY-CURABLE ELASTOMER COMPOSITION, MATERIAL FOR GASKET, GASKET, AND HARD DISK DEVICE Bridgestone Corporation (JP) 2012-03-07 EP disclosed
US-20120041096-A1 ENERGY-RAY-CURABLE ELASTOMER COMPOSITION, MATERIAL FOR GASKET, GASKET, AND HARD DISK DEVICE BRIDGESTONE CORPORATION (JP) 2012-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210163512-A1 ORGANIC SILICON COMPOUND AND PRODUCTION METHOD THEREFOR OR51E2, MSL1, SOS1 DGKA 4541/4885ALDH1A1 2353/4885TSHR 4456/4885
US-12240868-B2 Organic silicon compound and production method therefor OR51E2, MSL1, SOS1 DGKA 4541/4885ALDH1A1 2353/4885TSHR 4456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.